Trial Profile
Efficacy and tolerability of long-term tenofovir disoproxil fumarate in patients with chronic hepatitis B infection
Status:
Active, no longer recruiting
Phase of Trial:
Phase III
Latest Information Update: 28 Nov 2015
Price :
$35
*
At a glance
- Drugs Tenofovir disoproxil fumarate (Primary)
- Indications Hepatitis B
- Focus Therapeutic Use
- 18 Dec 2012 Results published in the Lancet.
- 18 Dec 2012 New trial record